Analysis of altered level of blood-based biomarkers in prognosis of COVID-19 patients.
Mahendra Raj ShresthaAjaya BasnetBasanta TamangSudip KhadkaRajendra MaharjanRupak MaharjanArun Bahadur ChandSuresh ThapaShiba Kumar RaiPublished in: PloS one (2023)
Assessing and monitoring the elevated levels of glucose, urea, ALT, AST, ALP, WBC, CRP, PCT, IL-6, ferritin, LDH, D-Dimer, and CPK-MB and the lowered levels of total protein, albumin, and platelet could provide a basis for evaluation of improved prognosis and effective treatment in patients with COVID-19.